|
Status |
Public on Nov 03, 2014 |
Title |
tamoxifen-day 3-3 |
Sample type |
RNA |
|
|
Source name |
mouse myocardium, left ventricle
|
Organism |
Mus musculus |
Characteristics |
strain: C57Bl6/J gender: male age: 12-20 weeks tissue: myocardium, left ventricle
|
Treatment protocol |
For intraperitoneal injection, 10mg tamoxifen free base (T5648, Sigma) was dissolved in 1mL peanut oil (Sigma) and then sonicated. 100microL (1.0 mg tamoxifen) was injected daily (40mg/kg/day, i.p.) for 5 days.
|
Growth protocol |
All mice were supplied with the same diet and water ad libitum; Mice were maintained on a 12-hour light/dark cycle in a temperature and humidity controlled environment.
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was preparted using TRIzol reagent (Invitrogen) from left ventricular myocardial tissue. Total RNA yield and purity (260nm:280nm) were determined spectrophotometrically. The integrity (RIN>9.0) of the re-suspended total RNA was determined using the RNA Nano Chip Kit on the Bioanalyzer 2100 and the 2100 Expert software (Agilent).
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
|
|
|
Hybridization protocol |
Standard Illumina hybridization protocol.
|
Scan protocol |
Standard Illumina scanning protocol.
|
Description |
Tamoxifen x3 days -3
|
Data processing |
The data were normalized using quantile normalization with Solo, a simple standalone tood implementing the quantile-quantile normalization method (Univ. of Strasbourg, France)
|
|
|
Submission date |
Feb 05, 2014 |
Last update date |
Nov 03, 2014 |
Contact name |
Andreas Sebastian Barth |
E-mail(s) |
[email protected]
|
Phone |
+1 410 614 0032
|
Organization name |
Johns Hopkins University
|
Department |
Medicine, Division of Cardiology
|
Lab |
Tomaselli
|
Street address |
720 Rutland Ave.
|
City |
Baltimore |
State/province |
MD |
ZIP/Postal code |
21205 |
Country |
USA |
|
|
Platform ID |
GPL6885 |
Series (1) |
GSE54681 |
Genome-wide changes in gene expression during the development and after recovery from heart failure in a mouse model of transient cardiomyopathy. |
|